What Researchers Did
Researchers measured insulin sensitivity and inflammation markers in overweight and obese men, with and without type 2 diabetes, during and after hyperbaric oxygen treatment (HBOT) sessions.
What They Found
In a small study of overweight and obese men, 11 without and 8 with type 2 diabetes, insulin sensitivity measured by glucose infusion rate rose during HBOT by 29 percent in men without diabetes (p equal to 0.01) and by 57 percent in men with type 2 diabetes (p equal to 0.04). The increase was maintained for 30 minutes after HBOT. Two inflammation markers, MCP-1 and TNF-alpha, were lower after HBOT, while IL-6 rose only in men without diabetes. In that group, the IL-6 rise correlated with the rise in insulin sensitivity (r squared 0.72, p equal to 0.004). Final analyses included 10 men without diabetes and 7 with it.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
The study was small, included only men, and reported no control group, so the findings cannot show lasting benefit or apply to women, and the explanation involving inflammation is only suggested.